Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04358276 · ClinicalTrials.gov registry record · NA
Technology-Enabled Activation of Skin Cancer Screening for Stem Cell Transplant Survivors and Their Primary Care Providers, TEACH Study
A NA study of Skin Carcinoma, sponsored by City of Hope Medical Center.
- Active
- Registry status
- NA
- Development phase
- 840
- Enrollment target
- 1
- Study location
NCT04358276 is a NA study of Skin Carcinoma that is active but no longer recruiting, run by City of Hope Medical Center. The registered enrollment target is 840 participants, above the 79-participant average among 4 other Skin Carcinoma trials with a reported enrollment target (963% higher). The trial reports 1 study location across 1 state.
The verdict
NCT04358276, a NA study of Skin Carcinoma, is active but no longer recruiting, sponsored by City of Hope Medical Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 840 participants
- Enrollment target
- 1
- Study location
Study Summary
This trial studies the impact of a 12-month invention focused on early detection of skin cancer and timely follow up in patients who underwent stem cell transplant and their primary care providers. Some stem cell transplant survivors may develop complications related to the treatment they received. Many of these complications may not be known for years after the treatment and preventive measures can be taken to reduce the chances that a complication will occur and encourage early detection. This study focuses on one complication that stem cell transplant survivors are at high risk of developing - skin cancer. An early diagnosis of skin cancer is important since the cancer is usually smaller, requires less extensive treatments, and has better outcomes. Teaching skin self-examination and encouraging patients to alert doctors to skin changes may provide an important opportunity for early detection of skin cancer.
Conditions Studied
Interventions
- OTHER Questionnaire Administration
- OTHER Educational Intervention
- OTHER Computer-Assisted Intervention
- DEVICE Dermatoscope
- OTHER Educational Intervention (Physician)
Study Locations (1)
California
- City of Hope Medical Center - Duarte
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 840 participants |
| Start Date | 2020-10-30 |
| Est. Completion | 2026-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04358276
The ClinicalTrials.gov registry entry for NCT04358276 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 840 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 79-participant average among 4 other Skin Carcinoma trials with a reported enrollment target (963% higher). The listed sponsor is City of Hope Medical Center, which has 582 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Skin Carcinoma appearing as the primary indexed condition, and to 5 interventions - of which Questionnaire Administration is the first listed.
NCT04358276 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT04358276 about?
NCT04358276 is a clinical study titled "Technology-Enabled Activation of Skin Cancer Screening for Stem Cell Transplant Survivors and Their Primary Care Providers, TEACH Study". This trial studies the impact of a 12-month invention focused on early detection of skin cancer and timely follow up in patients who underwent stem cell transplant and their primary care providers. Some stem cell transplant survivors may develop complications related to the treatment they received. ...
What is the current status of trial NCT04358276?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 840 participants. The study started on 2020-10-30. Estimated completion is 2026-03-31.
What conditions does trial NCT04358276 study?
This clinical trial studies the following conditions: Skin Carcinoma.
What interventions are being tested in trial NCT04358276?
The interventions under investigation include: Questionnaire Administration (OTHER), Educational Intervention (OTHER), Computer-Assisted Intervention (OTHER), Dermatoscope (DEVICE), Educational Intervention (Physician) (OTHER).
Who is sponsoring clinical trial NCT04358276?
This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04358276 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Skin Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
MoleMapper, Visiomed, and Confocal Microscopy in Screening Participants for Melanoma
ACTIVE NOT RECRUITING · NA
-
SMART Project in Preventing Skin Cancer
COMPLETED · NA
-
Effects of Lavender Aromatherapy on Patient Anxiety During Mohs Micrographic Surgery
COMPLETED · NA
-
Adaptive BRAF-MEK Inhibitor Therapy for Advanced BRAF Mutant Melanoma
ACTIVE NOT RECRUITING · Early Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.